Skip to main content
. 2011 Feb 7;192(3):373–382. doi: 10.1083/jcb.201010021

Figure 2.

Figure 2.

Illustration of current and potential applications of CTC technologies. The peripheral blood of a cancer patient is collected and processed through various CTC isolation technologies. CTCs are captured along with contaminating leukocytes. Immunostaining for specific markers and FISH for genomic amplification and translocation can be applied to CTCs. DNA or RNA can be extracted from the CTCs and subjected to sequencing, quantitative RT-PCR (qRT-PCR), and potential expression profile analysis. Viable cells can be released and propagated in cell culture.